GC Biopharma Corp. (KRX: 006280)

Market Cap	1.81T
Revenue (ttm)	1.62T
Net Income (ttm)	-38.20B
Shares Out	11.41M
EPS (ttm)	-3,347.42
PE Ratio	n/a
Forward PE	67.86
Dividend	1,500.00 (0.94%)
Ex-Dividend Date	n/a

Volume	40,296
Open	158,600
Previous Close	159,400
Day's Range	157,100 - 161,200
52-Week Range	93,000 - 177,500
Beta	1.03
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About GC Biopharma

GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-GCC injection (inj.) for hypoalbuminemia and shock in acute hemorrhage, as well as low synthesis of albumin; Antithrombin-III (AT-III) inj. for heredit...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 2,016
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 006280